Avalo Therapeutics, Inc. · NASDAQ:AVTX

TCG Crossover GP II, LLC reported a 7.90% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event May 5, 2026 · Filed May 12, 2026

TCG Crossover GP II, LLC reported a 7.90% stake in Avalo Therapeutics, Inc., 3,017,120 shares, as a passive investor on May 5, 2026. Filed May 12, 2026 (Schedule 13G).

Stake
7.90%
Shares
3,017,120
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
TCG Crossover GP II, LLC7.90%3,017,120
TCG Crossover Fund II, L.P.7.90%3,017,120
Chen Yu7.90%3,017,120

Source

View original at SEC

Related